Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio', a blood test to help in the diagnosis of brain tumors. This is the thir
Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system. The research, published in Cancer Cell in September, could lead to a new therapeutic option for patients with these types of tumors.
Inflammatory bowel disease (IBD) is an umbrella term for two diseases, Crohn's disease and ulcerative colitis, that are characterized by the prolonged inflammation of the gastrointestinal tract. This condition often leads to the development of colorectal tumors. Understanding the pathogenesi
After an intrepid, decade-long search, Johns Hopkins Medicine scientists say they have found a new role for a pair of enzymes that regulate genome function and, when missing or mutated, are linked to diseases such as brain tumors, blood cancers and Kleefstra syndrome a rare genetic, neurocog
Researchers have described prostate cancer cell dynamics at a single-cell resolution across the whole course of the disease, from the first stages to the point of androgen independence, where the tumour stops responding to hormone restriction therapy.
Surgery requires a variety of instruments and methods, as well as the skill of the surgeon, especially when removing cancerous tumours. Surgery to remove lung cancer tumours will now be a little bit more precise thanks to the new imaging agent Cytalux.
From the onset of the disease through the point of androgen independence, where the tumour no longer responds to hormone restriction therapy, researchers have described prostate cancer cell dynamics at a single-cell resolution over the course of the disease.
Researchers examine the local communication between endothelial cells and tumors cells and its effects on endothelial cell orientation. The approach uses co-cultured human umbilical vein endothelial cells and breast epithelial tumor cell lines to simulate the tumor-endothelial interaction. T
Study revealed the possible cause of pancreatic cancer. The findings hold implications for the targeted treatment of pancreatic ductal adenocarcinoma (PDAC), which accounts for the vast majority of all pancreatic tumors and is the fourth-leading cause of cancer-related deaths worldwide.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
A protein that can predict whether or not DNA-damaging treatments will be effective when it is found in high concentrations in breast cancer tumors, according to researchers.